Sohini Das, Anjali Singh, Aneeka Chatterjee, Nitin Kumar, Surajeet Das Gupta

Stories by Sohini Das, Anjali Singh, Aneeka Chatterjee, Nitin Kumar, Surajeet Das Gupta

Can India's Gold, Silver Slash US Trade Deficit?

Can India's Gold, Silver Slash US Trade Deficit?

Rediff.com   10 Mar 2025

Gem and Jewellery Export Promotion Council says step will balance trade deficit with the US.

This will Likely Shape the Future of Pharma Inc

This will Likely Shape the Future of Pharma Inc

Rediff.com   8 Mar 2025

Indian pharmaceutical companies may have units abroad as part of "distributed manufacturing" across various locations, according to industry veterans. This may come about over the next five to 10 years.

'US tariff issue is an overhanging sword'

'US tariff issue is an overhanging sword'

Rediff.com   7 Mar 2025

Firodia talked about his plans for the EV-components business, and the components business at large for the group

DPIIT to Rope In Corporates For Startup Boost

DPIIT to Rope In Corporates For Startup Boost

Rediff.com   6 Mar 2025

Companies have been approached to set up incubation centres that will offer financial and non-financial support to manufacturing startups at various levels.

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com   6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

Top Biz Families Fuel 20% Of CSR Spends

Top Biz Families Fuel 20% Of CSR Spends

Rediff.com   6 Mar 2025

Tatas, Ambanis, Adanis, Birlas contributed an average of Rs 800 crore to Rs 1,000 crore per family group.

Can Tesla Make In India For Below $23,000?

Can Tesla Make In India For Below $23,000?

Rediff.com   5 Mar 2025

The Indian automotive market offers around 1 million units annual volume opportunity at a price above $23,000.

2024 an inflection point in race to become unicorn

2024 an inflection point in race to become unicorn

Rediff.com   28 Feb 2025

Startups that became unicorns in 2024 took an average of nine years and six months to reach $1 billion valuation, reflecting the impact of a prolonged funding squeeze from PE/VC firms over the past few years.

IITs, IIMs Lose Grip on Unicorn Growth

IITs, IIMs Lose Grip on Unicorn Growth

Rediff.com   28 Feb 2025

BITS has produced 10 startup unicorn founders in the US.

India Inc holds breath for Trump's new tariffs to kick in

India Inc holds breath for Trump's new tariffs to kick in

Rediff.com   27 Feb 2025

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.

Why Tesla Entry is No Major Threat

Why Tesla Entry is No Major Threat

Rediff.com   24 Feb 2025

Tesla needs to either sell the same models with reduced features to lower the cost for Indian market, or incur losses.

Audi shrugs off last year, plans to step on the gas

Audi shrugs off last year, plans to step on the gas

Rediff.com   21 Feb 2025

Audi plans to focus the Indian market, including deepening market penetration and increasing sales volume.

iPhone Revenue Nears Tata Steel

iPhone Revenue Nears Tata Steel

Rediff.com   19 Feb 2025

Apple Inc's iPhones assembled in India achieved market revenues of Rs 162,000 crore. Tata Steel's revenue for the same period was Rs 162,324 crore.

USAID Funding To India Declines Amid Trump's Freeze

USAID Funding To India Declines Amid Trump's Freeze

Rediff.com   13 Feb 2025

'If the Bill and Melinda Gates Foundation cuts funds, there could be more impact.'

Lack of charging infra a shock for booming EV market

Lack of charging infra a shock for booming EV market

Rediff.com   11 Feb 2025

Proliferation of home chargers of around 7 KWh and above, which take six to seven hours to fully charge a car depending on the model, bring running costs down by a third or so. That, coupled with the increasing range of modern electric cars, can lead to a massive increase in sales.

Highest Selling New Drug In India Is...

Highest Selling New Drug In India Is...

Rediff.com   11 Feb 2025

Enhertu currently costs around Rs 1.6 lakh per 100-milligram injection.

'Tariffs will hurt insurance, patients and everyone'

'Tariffs will hurt insurance, patients and everyone'

Rediff.com   10 Feb 2025

After registering a net profit of Rs 25.1 crore in Q3FY25 and consolidated revenues growing by 7 per cent on a like-for-like basis, Siddharth Mittal, chief executive officer (CEO) and managing director, Biocon, told Sohini Das/Business Standard in a virtual interaction that local manufacturing in the US is a trade off between cost and qualifying to do business there.

Zepto Grabs #2 Spot in Global Food Apps

Zepto Grabs #2 Spot in Global Food Apps

Rediff.com   6 Feb 2025

Zomato is at 5, Swiggy at 9, Blinkit at 10.

Budget Prepares For Rise In Cancer Cases

Budget Prepares For Rise In Cancer Cases

Rediff.com   3 Feb 2025

Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector?

Trump's Tariff War: India Waits, Watches

Trump's Tariff War: India Waits, Watches

Rediff.com   3 Feb 2025

'We have to be prepared for the larger disruption that is likely to take place.'